The FDA has approved updated labeling for Vyjuvek (beremagene geperpavec-svdt), a topical gene therapy for dystrophic epidermolysis bullosa.
The ACIP voted to recommend that the combined MMRV vaccine not be given before age 4 years and will vote on the hepatitis B vaccine Friday.
Skin cancer risk was significantly reduced with nicotinamide initiation and more so with initiation after a first skin cancer.
DermaRite Industries widened its recall of personal care products contaminated with Burkholderia cepacia complex.
Topical ruxolitinib does not carry the same safety profile as oral JAK inhibitors for AD, which may warrant reconsideration of the boxed warning.
Officials from the Centers for Medicare and Medicaid Services moved to close Miami’s Life Alliance Organ Recovery Agency over safety issues.
Patients with protoporphyria experience high rates of impaired daily function, emotional and psychosocial distress, and health care use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback